Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
824.50    -1.50 (-0.18%)
Bid:
822.50
Ask:
827.00
Spread: 4.50 (0.547%)
Market Cap: £949.61m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Statement

19 Apr 2022 07:00

RNS Number : 4954I
Kainos Group plc
19 April 2022
 

19 April 2022

Kainos Group plc

("Kainos" or "the Company")

Trading Update

 

Kainos Group plc (KNOS), a leading IT provider, operating across two specialist business areas, Digital Services and its Workday Practice, today issues a trading update for the year ended 31 March 2022.

 

Trading in the period continued to be very strong across both business areas as new and existing clients maintained or increased their levels of investment in digital solutions. As a result, for the full year ending 31 March 2022, the Board expects revenue and adjusted profit to be in line with current consensus forecasts. 

 

Against a backdrop of strong market demand in the UK, our experienced Digital Services teams continue to deliver major transformation programmes to new and existing clients across the Public, Commercial and Healthcare sectors. Our international engagements continue to grow in scale, with positive progress in both Europe and Canada.

 

In the fast-growing Workday services market, our Workday Practice continues to benefit from our well-established global presence. This has been enhanced through the year with the expertise of our new colleagues who joined via the acquisitions of Cloudator (55 people, Europe), Une Consulting (42 people, Argentina), Blackline Group (50 people, USA) and Planalyse (6 people, Netherlands).

 

Our Smart Product Suite for Workday has maintained its very strong growth trajectory. Smart Test, our automated testing platform for Workday, continues to expand its international client base, signing a record number of new clients during the year. Smart Audit, launched in August 2021, has already established a strong cohort of customers, from our existing client base as well as securing new clients.

 

Our performance has been underpinned by our long-term customer relationships, and we remain extremely grateful to our customers for the trust that they have placed in Kainos to help them deliver their ambitious digital projects.

 

Our success is generated by our people, who continue to excel in delivering high-impact solutions to our customers. Despite the increased global demand for digital talent, we continue to retain, develop and attract high quality people; we now have 2,692 colleagues based in over twenty countries (31 March 2021: 2,024 people), an increase of 33% on the prior year.

 

Looking ahead, our robust pipeline, strong balance sheet and significant contracted backlog underpin our confidence in our outlook. As a result, we believe that we are well-positioned for further growth and remain confident in our strategy.

 

The announcement of our results for the full year ended 31 March 2022 will be made on 23 May 2022.

 

Ends

 

 

 

For further information, please contact: 

 

Kainos via FTI Consulting LLP 

Brendan Mooney, Chief Executive Officer 

Richard McCann, Chief Financial Officer 

 

Investec Bank plc +44 20 7597 5970 

Patrick Robb / Ben Griffiths 

 

Canaccord Genuity +44 20 7523 4606 

Simon Bridges / Andrew Potts 

 

FTI Consulting LLP +44 20 3727 1000 

Matt Dixon / Dwight Burden / Kwaku Aning

 

About Kainos 

Kainos Group plc is a UK-headquartered IT provider, across two specialist business areas, Digital Services and the Workday Practice.

 

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible and cost-effective, and that they provide better outcomes for users.

 

Our Workday Practice is focused on the deployment of Workday Inc's Finance, HR and Planning software to leading organisations across the public, commercial and healthcare sectors. We are one of Workday's most respected partners, experienced in complex deployment and integrations and trusted by our customers to launch, test, expand and safeguard their Workday systems. We are also the leader in automated testing of customers' unique Workday configurations.

 

Our people are central to our success. We employ more than 2,600 people across 12 offices in Europe and North America.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about what we do and who we are at www.kainos.com

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014. Prior to publication, certain information contained within this Announcement was deemed to constitute inside information for the purposes of Article 7 of MAR. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFAFWIEESEEL
Date   Source Headline
19th Aug 201912:02 pmRNSPrice Monitoring Extension
2nd Aug 20194:52 pmRNSHolding(s) in Company
1st Aug 20192:35 pmRNSTotal Voting Rights
31st Jul 201911:30 amRNSAnnual Report 2019
26th Jul 201911:36 amRNSHolding(s) in Company
24th Jul 20197:00 amRNSBoard Change
18th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20191:24 pmRNSDirector/PDMR Shareholding
4th Jul 20193:10 pmRNSHolding(s) in Company
1st Jul 20192:09 pmRNSTotal Voting Rights
25th Jun 20198:33 amRNSHolding(s) in Company
24th Jun 20191:43 pmRNSHolding(s) in Company
17th Jun 20194:40 pmRNSHolding(s) in Company
17th Jun 20194:26 pmRNSDirector/PDMR Shareholding
31st May 20194:06 pmRNSTotal Voting Rights
29th May 20197:55 amRNSHolding(s) in Company
29th May 20197:44 amRNSHolding(s) in Company
28th May 20197:00 amRNSPreliminary Results
1st May 20196:10 pmRNSTotal Voting Rights
1st May 20196:10 pmRNSBlock listing Interim Review
16th Apr 20197:00 amRNSTrading Statement
1st Apr 20193:29 pmRNSTotal Voting Rights
21st Mar 20194:28 pmRNSHolding(s) in Company
7th Mar 201911:31 amRNSDirector/PDMR Shareholding
28th Feb 201912:11 pmRNSTotal Voting Rights
25th Feb 20194:47 pmRNSHolding(s) in Company
12th Feb 20197:00 amRNSKainos announces site purchase for new Belfast HQ
6th Feb 20195:11 pmRNSAdmission of Shares to Trading
6th Feb 20193:59 pmRNSHolding(s) in Company
5th Feb 20194:01 pmRNSHolding(s) in Company
4th Feb 20194:11 pmRNSTotal Voting Rights
4th Feb 20197:00 amRNSTrading Update
6th Dec 20184:35 pmRNSPrice Monitoring Extension
5th Dec 20181:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20181:38 pmRNSTotal Voting Rights
26th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSInterim Results
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20185:02 pmRNSHolding(s) in Company
1st Nov 20183:57 pmRNSAdmission of Shares to Trading
1st Nov 20183:53 pmRNSBlock Admission
1st Nov 20183:49 pmRNSTotal Voting Rights
18th Oct 201812:07 pmRNSSecond Price Monitoring Extn
18th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20187:00 amRNSChange of Registered Office
1st Oct 20184:47 pmRNSTotal Voting Rights
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.